Clinical Trial Update: Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety and toxicity of Polyphenon E (EGCG) in HIV-1-infected individuals has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Polyphenon E (EGCG) (epigallocatechin-3-gallate)

Snippet

Sponsor: Baylor College of Medicine | Conditions: HIV Infection | Phase 1 | Status: COMPLETED | Results posted: 2023-05-19